Xinjian Wan Selected Research

Xinjian Wan Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2013
5	Cholangiocarcinoma 10/2020 - 01/2016
4	Gallstones (Gallstone) 01/2022 - 11/2016
4	Pathologic Constriction (Stenosis) 08/2021 - 01/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 01/2013
2	Metaplasia 11/2020 - 01/2020
2	Fibrosis (Cirrhosis) 03/2020 - 10/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2020 - 10/2018
2	Non-alcoholic Fatty Liver Disease 03/2020 - 01/2020
2	Disease Progression 01/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 12/2015 - 05/2015
2	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 01/2014
1	Colitis 11/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2019
1	Cholangitis 11/2018
1	Liver Failure 10/2018
1	Ulcerative Colitis 01/2018
1	Infections 05/2017
1	Cholelithiasis 11/2016
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2015
1	Nausea 07/2015
1	Dizziness (Lightheadedness) 07/2015
1	Hypoxia (Hypoxemia) 11/2013
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 11/2013

Drug/Important Bio-Agent (IBA)

5	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2020
3	CholesterolIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 05/2015
3	Keratin-19 (Keratin 19)IBA 10/2020 - 12/2015
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2020 - 12/2015
3	MetalsIBA 11/2018 - 11/2016
2	poly(lactide) (polylactic acid)IBA 08/2021 - 11/2016
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 11/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2013
2	MucinsIBA 10/2020 - 01/2018
2	InflammasomesIBA 03/2020 - 01/2020
2	CXC ChemokinesIBA 10/2018 - 01/2014
2	Pharmaceutical PreparationsIBA 06/2018 - 11/2016
2	CateninsIBA 05/2016 - 12/2015
1	NF-kappa B (NF-kB)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	MatrinesIBA 11/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2021
1	Butyric Acid (Butanoic Acid)IBA 10/2021
1	PolydioxanoneIBA 08/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	AlloysIBA 01/2021
1	Messenger RNA (mRNA)IBA 11/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	13(1)-(2'-(2-pyridyl)ethylamine) chlorin e6IBA 01/2020
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 01/2020
1	7- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	spasmolytic polypeptideIBA 01/2020
1	AdiponectinIBA 01/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	Extracellular Matrix ProteinsIBA 10/2018
1	cupric sulfide (CuS)IBA 06/2018
1	VimentinIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	ethyleneIBA 11/2016
1	AcidsIBA 11/2016
1	caprolactoneIBA 11/2016
1	Sodium CholateIBA 11/2016
1	DiaminesIBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 05/2016
1	TitaniumIBA 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2016
1	SiliconesIBA 01/2016
1	Parasympatholytics (Antispasmodics)IBA 07/2015
1	pinaveriumIBA 07/2015
1	MicroRNAs (MicroRNA)IBA 07/2015
1	nasIBA 01/2015
1	Chemokine CXCL1IBA 01/2014
1	LigandsIBA 01/2014
1	Citric Acid (Citrate)FDA LinkGeneric 11/2013
1	Small Interfering RNA (siRNA)IBA 11/2013

Therapy/Procedure

4	Stents 08/2021 - 11/2016
2	Appendectomy 01/2019 - 01/2018
2	Therapeutics 06/2018 - 01/2015
1	Photochemotherapy (Photodynamic Therapy) 01/2020
1	Duodenoscopes 11/2018
1	Endoscopes 11/2018
1	Prostheses and Implants (Prosthesis) 11/2018
1	Precision Medicine 06/2018
1	Brachytherapy 01/2016
1	Liver Transplantation 01/2015
1	Aftercare (After-Treatment) 01/2015